AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic …
Over the last 12 months, insiders at AdaptHealth Corp. have bought $0 and sold $5.69M worth of AdaptHealth Corp. stock.
On average, over the past 5 years, insiders at AdaptHealth Corp. have bought $4.24M and sold $45.05M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 720 shares for transaction amount of $10,152 was made by Clemens Jason A (Chief Financial Officer) on 2023‑08‑10.
2024-11-13 | Sale | director | 7,000 0.0053% | $10.80 | $75,600 | -8.68% | ||
2024-09-20 | Sale | Former Chief Operating Officer | 25,000 0.0186% | $11.24 | $281,000 | -7.11% | ||
2024-08-29 | Sale | director | 4,000 0.003% | $11.26 | $45,040 | -2.26% | ||
2024-05-24 | Sale | director | 1,409 0.0011% | $9.97 | $14,048 | +7.45% | ||
2024-05-23 | Sale | director | 3,100 0.0024% | $9.90 | $30,690 | +12.32% | ||
2024-03-12 | Sale | *Possible Member of 10% Group | 114,906 0.0832% | $10.70 | $1.23M | -3.60% | ||
2024-03-11 | Sale | *Possible Member of 10% Group | 182,607 0.1361% | $11.02 | $2.01M | -3.73% | ||
2024-03-08 | Sale | *Possible Member of 10% Group | 52,487 0.0387% | $10.93 | $573,652 | -3.69% | ||
2024-03-04 | Sale | Chief Technology Officer | 135,443 0.0978% | $10.41 | $1.41M | -1.32% | ||
2023-12-04 | Sale | director | 2,255 0.0017% | $9.30 | $20,972 | +9.51% | ||
2023-08-11 | Sale | director | 196,839 0.148% | $14.02 | $2.76M | -31.92% | ||
2023-08-10 | Sale | director | 128,788 0.0963% | $14.05 | $1.81M | -32.36% | ||
2023-08-10 | Sale | Chief Technology Officer | 200,000 0.151% | $14.18 | $2.84M | -32.36% | ||
2023-08-10 | Chief Financial Officer | 720 0.0005% | $14.10 | $10,152 | -32.36% | |||
2023-02-06 | Sale | 540,000 0.4146% | $20.75 | $11.21M | -47.00% | |||
2023-02-01 | Sale | 44,789 0.0328% | $21.00 | $940,569 | -49.23% | |||
2023-01-31 | Sale | 55,211 0.0403% | $21.00 | $1.16M | -48.97% | |||
2023-01-18 | Sale | director | 4,789 0.0037% | $22.00 | $105,358 | -47.88% | ||
2023-01-13 | Sale | director | 10,201 0.0074% | $21.00 | $214,221 | -47.97% | ||
2023-01-12 | Sale | director | 340,000 0.2418% | $20.00 | $6.8M | -46.02% |
WOLF DALE B | director | 74889 0.0557% | $9.84 | 4 | 1 | +33.69% |
GRIGGS STEPHEN P | Chief Executive Officer | 3576927 2.6583% | $9.84 | 3 | 0 | +7.28% |
SkyKnight Capital Fund II, L.P. | director | 2684543 1.9951% | $9.84 | 6 | 0 | +25% |
Ebbel Matthew | 200000 0.1486% | $9.84 | 10 | 0 | +17.68% | |
Clemens Jason A | Chief Financial Officer | 194120 0.1443% | $9.84 | 3 | 0 | +15.91% |
One Equity Partners | $159.05M | 10.37 | 13.82M | 0% | +$0 | 57.85 | |
BlackRock | $157.05M | 10.24 | 13.64M | -3% | -$4.86M | <0.01 | |
Deerfield Management | $152.6M | 9.95 | 13.26M | -2.57% | -$4.03M | 0.37 | |
The Vanguard Group | $115.3M | 7.52 | 10.02M | +8.89% | +$9.42M | <0.01 | |
SkyKnight Capital | $98.76M | 6.44 | 8.58M | 0% | +$0 | 93.02 |